Barclays Forecasts Strong Price Appreciation for Charles River Laboratories International (NYSE:CRL) Stock
Charles River Laboratories International (NYSE:CRL – Get Free Report) had its target price upped by equities researchers at Barclays from $145.00 to $155.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has an “equal weight” rating on the medical research company’s stock. Barclays‘s price objective indicates a potential upside of 11.64% from […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) had its target price upped by equities researchers at Barclays from $145.00 to $155.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has an “equal weight” rating on the medical research company’s stock. Barclays‘s price objective indicates a potential upside of 11.64% from […]
